Test Price
2,800 AED✅ Home Collection Available
HOXD13-Related Brachydactyly-Syndactyly Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary
This advanced genetic test provides comprehensive analysis of the HOXD13 gene to detect mutations causing Brachydactyly-Syndactyly Syndrome. We ensure 99.9% diagnostic sensitivity via ISO-accredited NGS processing, with premium VIP mobile phlebotomy and temperature-controlled cold-chain home collection. Post-test telephonic clinical guidance with a Consultant Medical Genetics is included.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Next Generation Sequencing (NGS)
99.9% via NGS & Sanger Confirmation
3 to 4 Weeks
Test Overview & Methodology
The HOXD13 NGS test is a definitive diagnostic tool for confirming Brachydactyly-Syndactyly Syndrome, a hereditary limb malformation disorder. This analysis sequences the HOXD13 gene with ultra-high precision to identify pathogenic mutations causing syndactyly and brachydactyly, enabling accurate genetic diagnosis for family planning and clinical management.
| Feature | Our Test (UAE Gold Standard) | Closest Alternative |
|---|---|---|
| Precision | Full Gene NGS with Copy Number Variation (CNV) Analysis | Partial Gene Sanger Sequencing |
| Methodology | NGS (Illumina NovaSeq) + Sanger Confirmation | Single-Exon PCR |
| Speed | 3-4 Weeks with ISO 9001:2015 Certified Reporting | 6-8 Weeks Standard Processing |
Physician Insight & Safety Protocols
"Interpreting a HOXD13 result requires deep phenotyping. A missense variant in the homeodomain is profoundly different from a polyalanine tract expansion; each carries distinct implications for limb development and familial recurrence. This is precisely why our post-test consultation correlates the genotype with your specific dysmorphology findings, ensuring no variant is misunderstood."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⛔ Medication Advisory
Do not discontinue prescribed medication or adjust therapy based solely on this genetic report without consulting the ordering physician or our specialist.
🚨 Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Neonates with unstable temperature; patients with active systemic infection; individuals unable to provide a 2cc EDTA whole blood sample.
- Emergency Flags: Seek immediate care if limb anomalies are associated with respiratory distress, severe feeding difficulties, or signs of spinal cord tethering.
- Pediatric Mandate: In strict compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability, a valid parent/guardian consent and a DHA-licensed pediatrician's requisition is mandatory before sample collection for minors. No home collection for minors without guardian physical presence.
Patient FAQ & Clinical Guidance
1. What is the clinical utility of the HOXD13 gene test for my child’s hand anomalies?
The HOXD13 NGS test definitively identifies pathogenic DNA variants causing Brachydactyly-Syndactyly Syndrome to guide precise orthopedic and surgical management plans. A positive result enables targeted interventions and predictive family planning.
2. How does UAE’s PDPL protect my genetic data when I take this test?
Your genomic data is de-identified, encrypted, and stored within sovereign UAE servers strictly under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. We never share data with third parties without explicit, revocable consent.
3. Can an FTA card sample be collected at home for my infant for this specific HOXD13 test?
Yes, our pediatric-trained VIP phlebotomists perform a single-drop heel stick onto an ISO-certified FTA card for infants from home. This method is stable at ambient temperature and validated for NGS-based testing. Home collection is available daily from 8 AM to 11 PM.
4. How long does it take to get the results?
The clinical turnaround time is 3 to 4 weeks from sample receipt. This includes NGS sequencing, bioinformatics analysis, Sanger confirmation, and expert clinical review by our Consultant Medical Genetics.
UAE Regulatory & Data Privacy Adherence
Your genetic data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All samples are processed in our DHA-licensed laboratory (License No. 1143) with ISO 15189 accredited protocols. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring full transparency and safety. No data is transferred outside the UAE without explicit consent.
Clinical & Logistical Metadata
| Test Name | HOXD13-Related Brachydactyly-Syndactyly Syndrome Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (2 mL EDTA) or FTA Card (infant heel stick) |
| Methodology Used | Next Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | Q70.0, Q71.8 |
| LOINC Code | 90553-1 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians